The Leadership Team at Palatin Technologies is responsible for setting the strategic direction and overall vision of the company. This team comprises key executives who oversee various functions such as product development, business development, regulatory affairs, and preclinical research, ensuring alignment with the company's mission to develop innovative biopharmaceuticals. Their collaborative efforts drive decision-making, resource allocation, and the cultivation of partnerships to advance novel therapies targeting melanocortin peptide receptors.
Carl Spana
CEO, President & Director
James E. Hattersley
SVP, Business Development
John Dodd
SVP, Preclinical Development
John K.A. Prendergas...
Founder & Chairman
Michael B. Raizman
Chief Medical Officer
Paul Kayne
VP, Biological Sciences
Robert Jordan
SVP, Program Operations
Samrat Sisodia
VP, Regulatory Affairs & Quali...
Stephen A. Slusher
Chief Legal Officer
Stephen T. Wills
COO, CFO, Treasurer & Secretar...
View all